Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis

Area of Science:

• Endocrinology
• Metabolic Disorders
• Human Physiology

Background:

• Impaired glucose tolerance (IGT) is a precursor to type 2 diabetes.
• Understanding the specific pathophysiological events in IGT is crucial for early intervention.
• Previous studies suggest varying contributions of insulin secretion and sensitivity to IGT.

Purpose of the Study:

• To elucidate the specific mechanisms underlying impaired glucose tolerance (IGT).
• To differentiate the roles of insulin sensitivity (SI) and glucose effectiveness (SG) in IGT pathogenesis.
• To investigate insulin secretory responses in different IGT subpopulations.

Main Methods:

• Minimal model approach applied to 15 individuals with IGT and 15 healthy controls.
• Classification of IGT subjects into insulin-sensitive and insulin-resistant subpopulations.
• Assessment of basal and dynamic insulin secretion, insulin sensitivity (SI), and glucose effectiveness (SG).

Main Results:

• IGT subjects exhibited normal insulin secretion but impaired SI and SG.
• Insulin-resistant IGT subpopulation showed significantly higher insulin secretion compared to insulin-sensitive IGT and normal controls.
• Both IGT subpopulations displayed significantly reduced glucose effectiveness (SG) compared to normal controls.

Conclusions:

• IGT pathogenesis involves impaired insulin sensitivity and glucose effectiveness.
• Insulin resistance in IGT necessitates an exaggerated insulin secretory response to maintain glucose homeostasis.
• Reduced glucose effectiveness is a common feature across different types of IGT.